4/16
07:00 am
igc
IGC-AD1’s Interim Phase 2 Data Show a Reduction in Alzheimer’s Agitation at Week Two
Medium
Report
IGC-AD1’s Interim Phase 2 Data Show a Reduction in Alzheimer’s Agitation at Week Two
4/9
09:00 am
igc
IGC Pharma Adds Advisor in Artificial Intelligence
High
Report
IGC Pharma Adds Advisor in Artificial Intelligence
3/26
03:00 pm
igc
IGC Pharma Announces $3 Million Unregistered Private Placement of its Common Stock
Low
Report
IGC Pharma Announces $3 Million Unregistered Private Placement of its Common Stock
3/20
11:00 am
igc
IGC Pharma Announces Positive Interim Results for IGC-AD1 in Reducing Alzheimer’s Agitation
Medium
Report
IGC Pharma Announces Positive Interim Results for IGC-AD1 in Reducing Alzheimer’s Agitation
3/20
07:00 am
igc
IGC PHARMA Announces its Participation at the Benzinga Virtual Healthcare Summit 2024
Low
Report
IGC PHARMA Announces its Participation at the Benzinga Virtual Healthcare Summit 2024
3/12
03:00 pm
igc
IGC Pharma (IGC): Healthcare Leader Terry Lierman Joins Board to Advance Alzheimer’s Pipeline
Low
Report
IGC Pharma (IGC): Healthcare Leader Terry Lierman Joins Board to Advance Alzheimer’s Pipeline
2/28
01:00 pm
igc
Promising Results: TGR-63 Enhances Memory in Alzheimer's Mouse Model
Medium
Report
Promising Results: TGR-63 Enhances Memory in Alzheimer's Mouse Model
2/23
12:01 pm
igc
IGC Pharma Announces Equity Analyst Coverage by Ascendiant with a “Buy” Recommendation and $3.00 Price Target
Medium
Report
IGC Pharma Announces Equity Analyst Coverage by Ascendiant with a “Buy” Recommendation and $3.00 Price Target
2/16
07:05 pm
igc
IGC Pharma Reports Third Quarter Fiscal 2024 Results
Low
Report
IGC Pharma Reports Third Quarter Fiscal 2024 Results
2/1
09:20 am
igc
IGC Pharma Announces TGR-63 Reduces Agitation in Alzheimer's Mouse Model
Low
Report
IGC Pharma Announces TGR-63 Reduces Agitation in Alzheimer's Mouse Model